$JXN
Jackson Financial Inc. Stock $jxn

$jxn Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000182299322000009 Filed on March 07, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$1.636B	$8.848B	$659.6M
YoY Change	148.01%	175.98%
Cost Of Revenue		$913.0M
YoY Change		-28.89%
Gross Profit		$7.935B
YoY Change		312.85%
Gross Profit Margin		89.68%
Selling, General & Admin	$1.059B	$4.119B	$1.707B
YoY Change	-37.98%	-0.35%
% of Gross Profit		51.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$11.00M
YoY Change		0.0%
% of Gross Profit		0.14%
Operating Expenses	$856.5M	$4.764B	$756.6M
YoY Change	13.2%	-15.06%
Operating Profit		$3.171B
YoY Change		-186.01%
Interest Expense	-$18.00M	$37.00M	-$7.400M
YoY Change	143.24%	-57.95%
% of Operating Profit		1.17%
Other Income/Expense, Net	-$13.10M	$111.0M	-$58.80M
YoY Change	-77.72%	-167.93%
Pretax Income	$748.3M	$4.047B	-$163.2M
YoY Change	-558.52%	-262.46%
Income Tax	$87.30M	$602.0M	-$273.1M
% Of Pretax Income	11.67%	14.88%
Net Earnings	$585.3M	$3.183B	$75.70M
YoY Change	673.18%	-294.8%
Net Earnings / Revenue	35.78%	35.97%	11.48%
Basic Earnings Per Share	$6.32	$33.86
Diluted Earnings Per Share	$6.196M	$33.69	$801.4K
COMMON SHARES
Basic Shares Outstanding		93.99M shares
Diluted Shares Outstanding		94.47M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.623B	$2.623B	$2.019B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$72.81B	$72.81B
YoY Change		-6.97%
Other Assets	$954.0M	$954.0M
YoY Change		-9.81%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$375.5B	$375.5B	$353.5B
YoY Change	6.23%	6.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$913.0M	$913.0M
YoY Change		6764.66%
LONG-TERM LIABILITIES
Long-Term Debt	$2.649B	$2.649B
YoY Change		722.67%
Other Long-Term Liabilities	$3.985B	$3.985B
YoY Change		-35.05%
Total Long-Term Liabilities	$6.634B	$6.634B
YoY Change		2.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$913.0M	$913.0M
Total Long-Term Liabilities	$6.634B	$6.634B
Total Liabilities	$364.4B	$365.1B	$343.5B
YoY Change	6.08%	6.12%
SHAREHOLDERS EQUITY
Retained Earnings	$2.809B		-$324.0M
YoY Change	-966.98%
Common Stock	$1.000M		$1.000M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$211.0M		$0.00
YoY Change
Treasury Stock Shares	5.779M shares		0.000 shares
Shareholders Equity	$10.39B	$10.39B	$9.429B
YoY Change
Total Liabilities & Shareholders Equity	$375.5B	$375.5B	$353.5B
YoY Change	6.23%	6.23%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$585.3M	$3.183B	$75.70M
YoY Change	673.18%	-294.8%
Depreciation, Depletion And Amortization		$11.00M
YoY Change		0.0%
Cash From Operating Activities	$2.166B	$5.743B	$1.330B
YoY Change	62.92%	52.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.920B	$554.0M	-$629.8M
YoY Change	204.87%	-265.87%
Cash From Investing Activities	-$1.920B	-$1.296B	-$629.8M
YoY Change	204.87%	-70.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$211.0M
YoY Change		-142.2%
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	-97.40M	-$3.835B	-129.1M
YoY Change	-24.55%	-699.22%
NET CHANGE
Cash From Operating Activities	2.166B	$5.743B	1.330B
Cash From Investing Activities	-1.920B	-$1.296B	-629.8M
Cash From Financing Activities	-97.40M	-$3.835B	-129.1M
Net Change In Cash	148.9M	$612.0M	570.8M
YoY Change	-73.91%	628.57%
FREE CASH FLOW
Cash From Operating Activities	$2.166B	$5.743B	$1.330B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001822993
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2020Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-40274
CY2021	dei	Entity Registrant Name EntityRegistrantName	Jackson Financial Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0486152
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Corporate Way
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Lansing
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48951
CY2021	dei	City Area Code CityAreaCode	517
CY2021	dei	Local Phone Number LocalPhoneNumber	381-5500
CY2021	dei	Security12b Title Security12bTitle	Class A Common Stock, Par Value $0.01 Per Share
CY2021	dei	Trading Symbol TradingSymbol	JXN
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1589000000	USD
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Public Float EntityPublicFloat	1900000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87425691	shares
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Dallas, TX
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	14000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	49378000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	54141000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	51547000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	59075000000	USD
CY2021Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	1711000000	USD
CY2020Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	1277000000	USD
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	117000000	USD
CY2020Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	105000000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	279000000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	193000000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	179000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	11482000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10728000000	USD
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3467000000	USD
CY2020Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3454000000	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	2220000000	USD
CY2021Q4	us-gaap	Other Investments OtherInvestments	3199000000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	2366000000	USD
CY2021Q4	us-gaap	Investments Investments	74227000000	USD
CY2020Q4	us-gaap	Investments Investments	80488000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2623000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2019000000	USD
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	503000000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	558000000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14249000000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13897000000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	12000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	13000000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	33126000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	35270000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	954000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1058000000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	853000000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	1103000000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	248949000000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219063000000	USD
CY2021Q4	us-gaap	Assets Assets	375484000000	USD
CY2020Q4	us-gaap	Assets Assets	353456000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	17629000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	21490000000	USD
CY2021Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	59689000000	USD
CY2020Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	64538000000	USD
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3639000000	USD
CY2020Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3627000000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	29007000000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	31972000000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2649000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	322000000	USD
CY2020Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1113000000	USD
CY2021Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	913000000	USD
CY2020Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	1103000000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	56000000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	3944000000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	3876000000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	248949000000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219063000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	364410000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	343533000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6051000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5927000000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5778649	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	211000000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	0	USD
CY2020Q4	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	4000000	USD
CY2021Q4	jxn	Equity Compensation Reserve EquityCompensationReserve	0	USD
CY2020Q4	jxn	Equity Compensation Reserve EquityCompensationReserve	8000000	USD
CY2021Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	194000000	USD
CY2020Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	766000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1744000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3821000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2809000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-324000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10394000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9429000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	680000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	494000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11074000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9923000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	375484000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	353456000000	USD
CY2021	jxn	Fee Income FeeIncome	7670000000	USD
CY2020	jxn	Fee Income FeeIncome	6604000000	USD
CY2019	jxn	Fee Income FeeIncome	6413000000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	133000000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	160000000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	567000000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	3429000000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2829000000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	3143000000	USD
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2478000000	USD
CY2020	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6451000000	USD
CY2019	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6714000000	USD
CY2021	us-gaap	Other Income OtherIncome	94000000	USD
CY2020	us-gaap	Other Income OtherIncome	64000000	USD
CY2019	us-gaap	Other Income OtherIncome	69000000	USD
CY2021	us-gaap	Revenues Revenues	8848000000	USD
CY2020	us-gaap	Revenues Revenues	3206000000	USD
CY2019	us-gaap	Revenues Revenues	3478000000	USD
CY2021	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	913000000	USD
CY2020	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	1284000000	USD
CY2019	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	1464000000	USD
CY2021	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	868000000	USD
CY2020	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	1210000000	USD
CY2019	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	1641000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	37000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	88000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	99000000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2462000000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	984000000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	2066000000	USD
CY2021	jxn	Cost Of Reinsurance CostOfReinsurance	0	USD
CY2020	jxn	Cost Of Reinsurance CostOfReinsurance	2520000000	USD
CY2019	jxn	Cost Of Reinsurance CostOfReinsurance	0	USD
CY2021	jxn	Expense Income From Amortization Of Deferred Acquisition And Sales Inducement Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionAndSalesInducementCosts	521000000	USD
CY2020	jxn	Expense Income From Amortization Of Deferred Acquisition And Sales Inducement Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionAndSalesInducementCosts	-389000000	USD
CY2019	jxn	Expense Income From Amortization Of Deferred Acquisition And Sales Inducement Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionAndSalesInducementCosts	-981000000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4801000000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	5697000000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4289000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4047000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2491000000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	33.69
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-811000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-369000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-442000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	262000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	55000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-497000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	33.86
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.16
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.16
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-442000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-573000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	414000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	697000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2080000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1419000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	2623000000	USD
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	1000000	USD
CY2020	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	1000000	USD
CY2019	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	0	USD
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	3000000	USD
CY2020	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	4000000	USD
CY2019	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-1000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2622000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1368000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-214000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2180000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	262000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	55000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1106000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-211000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2125000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7974000000	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-442000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2622000000	USD
CY2019	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	39000000	USD
CY2019	us-gaap	Dividends Dividends	875000000	USD
CY2019	jxn	Adjustments To Additional Paid In Capital Return Of Capital AdjustmentsToAdditionalPaidInCapitalReturnOfCapital	2000000000	USD
CY2019	jxn	Stock Distributed During Period Value StockDistributedDuringPeriodValue	10000000	USD
CY2019	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	1000000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-4000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7322000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	USD
CY2020	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	13000000	USD
CY2020	jxn	Stock Issued During Period Value Issued For Debt Restructure StockIssuedDuringPeriodValueIssuedForDebtRestructure	2350000000	USD
CY2020	jxn	Stock Issued During Period Value Issued For Debt Restructure StockIssuedDuringPeriodValueIssuedForDebtRestructure	2350000000	USD
CY2020	jxn	Stock Issued During Period Value Issued For Debt Restructure StockIssuedDuringPeriodValueIssuedForDebtRestructure	2350000000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	500000000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18000000	USD
CY2020	jxn	Stock Distributed During Period Value StockDistributedDuringPeriodValue	18000000	USD
CY2020	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	8000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9923000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	USD
CY2021	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-76000000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	211000000	USD
CY2021	us-gaap	Dividends Dividends	50000000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	123000000	USD
CY2021	jxn	Stock Issued During Period Value Demerger StockIssuedDuringPeriodValueDemerger	5000000	USD
CY2021	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	-8000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11074000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	3445000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-1637000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-442000000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	182000000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	377000000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	189000000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2639000000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-7268000000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6573000000	USD
CY2021	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-21000000	USD
CY2020	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	440000000	USD
CY2019	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-330000000	USD
CY2021	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	868000000	USD
CY2020	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	1213000000	USD
CY2019	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	1648000000	USD
CY2021	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	553000000	USD
CY2020	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	593000000	USD
CY2019	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	641000000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-49000000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-55000000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-19000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	675000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-776000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-674000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	129000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	56000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	79000000	USD
CY2021	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	0	USD
CY2020	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	32000000	USD
CY2019	jxn	Cash Paid To Received From Reinsurance Transaction CashPaidToReceivedFromReinsuranceTransaction	-37000000	USD
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-55000000	USD
CY2020	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-36000000	USD
CY2019	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-38000000	USD
CY2021	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	269000000	USD
CY2020	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	1359000000	USD
CY2019	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	1788000000	USD
CY2021	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	757000000	USD
CY2020	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-792000000	USD
CY2019	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	267000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	377000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	429000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	355000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5743000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3777000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4368000000	USD
CY2021	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	19568000000	USD
CY2020	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	30094000000	USD
CY2019	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	10123000000	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	50000000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	45000000	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	423000000	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1747000000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1201000000	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1243000000	USD
CY2021	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	14733000000	USD
CY2020	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	28400000000	USD
CY2019	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	11068000000	USD
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	111000000	USD
CY2020	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	97000000	USD
CY2019	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	120000000	USD
CY2021	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	2427000000	USD
CY2020	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	2189000000	USD
CY2019	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1750000000	USD
CY2021	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	4836000000	USD
CY2020	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	5321000000	USD
CY2019	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	7041000000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	554000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-334000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	139000000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	50000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1296000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4333000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8329000000	USD
CY2021	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	20149000000	USD
CY2020	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	19635000000	USD
CY2019	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	22636000000	USD
CY2021	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	28788000000	USD
CY2020	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	23176000000	USD
CY2019	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	23132000000	USD
CY2021	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2664000000	USD
CY2020	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2561000000	USD
CY2019	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2646000000	USD
CY2021	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	476000000	USD
CY2020	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	1100000000	USD
CY2019	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2021	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	380000000	USD
CY2020	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	-80000000	USD
CY2019	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	-300000000	USD
CY2021	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	735000000	USD
CY2020	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-60000000	USD
CY2019	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	2345000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1593000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	28000000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	5000000	USD
CY2020	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	0	USD
CY2019	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	7000000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2021	jxn	Payment Of Dividends To Former Parent PaymentOfDividendsToFormerParent	0	USD
CY2020	jxn	Payment Of Dividends To Former Parent PaymentOfDividendsToFormerParent	0	USD
CY2019	jxn	Payment Of Dividends To Former Parent PaymentOfDividendsToFormerParent	875000000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	211000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
CY2020	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
CY2019	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	2000000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3835000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	640000000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1927000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	612000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	84000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2034000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1935000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3969000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1935000000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	395000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	30000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	81000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	31000000	USD
CY2021	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	370000000	USD
CY2020	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	418000000	USD
CY2019	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	1219000000	USD
CY2021	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	99000000	USD
CY2020	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	4000000	USD
CY2019	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	1000000	USD
CY2021	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	USD
CY2020	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	2350000000	USD
CY2019	jxn	Noncash Debt Restructuring NoncashDebtRestructuring	0	USD
CY2021	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	USD
CY2020	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	2350000000	USD
CY2019	jxn	Noncash Shares Issued In Settlement Of Debt Restructuring NoncashSharesIssuedInSettlementOfDebtRestructuring	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2623000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2019000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1935000000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	8000000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1935000000	USD
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	104960.3836276
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain amounts in the 2020 notes to consolidated financial statements have been reclassified to conform to the 2021 presentation.
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates or assumptions, as further discussed in the notes, include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessments as to whether certain entities are variable interest entities, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions impacting estimated future gross profits, including policyholder behavior, mortality rates, expenses, projected hedging costs, investment returns and policy crediting rates, used in the calculation of amortization of deferred acquisition costs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimates related to expectations of credit losses on certain financial assets and off balance sheet exposures;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Value of guaranteed benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors deemed appropriate. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the consolidated financial statements in the periods the estimates are changed.</span></div>
CY2019	us-gaap	Revenues Revenues	3478000000	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Revenues Revenues	8848000000	USD
CY2020	us-gaap	Revenues Revenues	3206000000	USD
CY2021Q4	us-gaap	Assets Assets	375484000000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4801000000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	5697000000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4289000000	USD
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3785000000	USD
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2488000000	USD
CY2019	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-866000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-369000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-497000000	USD
CY2020Q4	us-gaap	Assets Assets	353456000000	USD
CY2021Q4	jxn	Debt Securities Rated DebtSecuritiesRated	13000000	USD
CY2020Q4	jxn	Debt Securities Rated DebtSecuritiesRated	960000000	USD
CY2021Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2020Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2021Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51206000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	9000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2790000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	612000000	USD
CY2021Q4	us-gaap	Debt Securities DebtSecurities	53375000000	USD
CY2020Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	55523000000	USD
CY2020Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	14000000	USD
CY2020Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5117000000	USD
CY2020Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	169000000	USD
CY2020Q4	us-gaap	Debt Securities DebtSecurities	60457000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne	908000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	0	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	15000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	0	USD
CY2021Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne	923000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	8434000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	0	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	386000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	24000000	USD
CY2021Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	8796000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	14260000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	0	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	743000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	107000000	USD
CY2021Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	14896000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	9178000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	0	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	847000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	172000000	USD
CY2021Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	9853000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	9004000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	0	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	606000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	277000000	USD
CY2021Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	9333000000	USD
CY2021Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51206000000	USD
CY2021Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	9000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2790000000	USD
CY2021Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	612000000	USD
CY2021Q4	us-gaap	Debt Securities DebtSecurities	53375000000	USD
CY2021Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	117000000	USD
CY2020Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	123000000	USD
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	246000000	USD
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	11135000000	USD
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	1344	security
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	165000000	USD
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	6556000000	USD
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	315	security
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	366000000	USD
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	4006000000	USD
CY2021Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	104	security
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4000000	USD
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	44000000	USD
CY2020Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	12	security
CY2021Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	612000000	USD
CY2021Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	15141000000	USD
CY2021Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	1421	security
CY2020Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	169000000	USD
CY2020Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	6600000000	USD
CY2020Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	327	security
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	14000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	2000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	9000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	16000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	17000000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-3000000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	14000000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	381000000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	434000000	USD
CY2021	jxn	Gross Investment Income Loss GrossInvestmentIncomeLoss	2362000000	USD
CY2020	jxn	Gross Investment Income Loss GrossInvestmentIncomeLoss	2164000000	USD
CY2019	jxn	Gross Investment Income Loss GrossInvestmentIncomeLoss	2965000000	USD
CY2021	jxn	Derivative Trading Commission DerivativeTradingCommission	3000000	USD
CY2020	jxn	Derivative Trading Commission DerivativeTradingCommission	5000000	USD
CY2019	jxn	Derivative Trading Commission DerivativeTradingCommission	4000000	USD
CY2021	us-gaap	Depreciation Depreciation	11000000	USD
CY2020	us-gaap	Depreciation Depreciation	11000000	USD
CY2019	us-gaap	Depreciation Depreciation	11000000	USD
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	41000000	USD
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	43000000	USD
CY2019	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	52000000	USD
CY2021	jxn	Investment Expense Other InvestmentExpenseOther	66000000	USD
CY2020	jxn	Investment Expense Other InvestmentExpenseOther	68000000	USD
CY2019	jxn	Investment Expense Other InvestmentExpenseOther	85000000	USD
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	121000000	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	127000000	USD
CY2019	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	152000000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	3429000000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2829000000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	3143000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	169000000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	778000000	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	307000000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	88000000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	196000000	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	107000000	USD
CY2021	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	10000000	USD
CY2020	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	14000000	USD
CY2019	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	0	USD
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	27000000	USD
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	3000000	USD
CY2021	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	-62000000	USD
CY2020	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	61000000	USD
CY2019	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	0	USD
CY2021	jxn	Other Operating Gain Loss OtherOperatingGainLoss	49000000	USD
CY2020	jxn	Other Operating Gain Loss OtherOperatingGainLoss	-103000000	USD
CY2019	jxn	Other Operating Gain Loss OtherOperatingGainLoss	-8000000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	182000000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	377000000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	189000000	USD
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2478000000	USD
CY2020	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6451000000	USD
CY2019	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-6714000000	USD
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	2604000000	USD
CY2020	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	7612000000	USD
CY2019	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	2312000000	USD
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.95
CY2020	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.97
CY2019	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.96
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	9600000000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25533000000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6520000000	USD
CY2021Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3860000000	USD
CY2020Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2976000000	USD
CY2021	jxn	Interest And Principal Payment Deferral Repayment Period Covid19 InterestAndPrincipalPaymentDeferralRepaymentPeriodCOVID19	P1Y
CY2021Q4	jxn	Deferred Interest And Principal Payment Amount Covid19 DeferredInterestAndPrincipalPaymentAmountCOVID19	9000000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	179000000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-85000000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9000000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	108000000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	179000000	USD
CY2021Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	44000000	USD
CY2020Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	35000000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	6000000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	7000000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	2000000	USD
CY2021Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1887000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1447000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1671000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1691000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1420000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	3362000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11482000000	USD
CY2021Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1425000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1757000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1886000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1807000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1417000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	2432000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10728000000	USD
CY2020Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2021Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	USD
CY2021Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	6000000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11482000000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	USD
CY2020Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	0	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10728000000	USD
CY2020Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3500000000	USD
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3500000000	USD
CY2021Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	USD
CY2020Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1100000000	USD
CY2021Q2	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	236000000	USD
CY2021Q3	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	168000000	USD
CY2021Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	17000000	USD
CY2020Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	13000000	USD
CY2021Q4	jxn	Securities Loaned Minimum Fair Value Collateral Percent SecuritiesLoanedMinimumFairValueCollateralPercent	1.02
CY2021Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	17000000	USD
CY2020Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	13000000	USD
CY2021Q3	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0007
CY2020Q4	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0016
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1572000000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1100000000	USD
CY2021	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	2349000000	USD
CY2020	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	1486000000	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1875000000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-8323000000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-6573000000	USD
CY2021Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	1376000000	USD
CY2020Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	2185000000	USD
CY2021Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	1576000000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	2124000000	USD
CY2021Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	0	USD
CY2020Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	13000000	USD
CY2021Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	0	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	26000000	USD
CY2021Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	200000000	USD
CY2020Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	0	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1417000000	USD
CY2021Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	USD
CY2021Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Derivative Assets FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstDerivativeAssets	41000000	USD
CY2021Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	817000000	USD
CY2021Q4	jxn	Derivative Collateral Obligation To Return Securities By Counterparty DerivativeCollateralObligationToReturnSecuritiesByCounterparty	555000000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	4000000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	41000000	USD
CY2021Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	USD
CY2021Q4	jxn	Financial Instruments Amounts That Have Not Been Off Set Against Derivative Liabilities FinancialInstrumentsAmountsThatHaveNotBeenOffSetAgainstDerivativeLiabilities	41000000	USD
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	USD
CY2021Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	17000000	USD
CY2021Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	USD
CY2021Q4	us-gaap	Securities Loaned SecuritiesLoaned	17000000	USD
CY2021Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Securities Loaned FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstSecuritiesLoaned	0	USD
CY2021Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	17000000	USD
CY2021Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	USD
CY2021Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1572000000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1572000000	USD
CY2021Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Securities Sold Under Agreements To Repurchase FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1572000000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	1630000000	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	1630000000	USD
CY2021Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Derivative Liability Securities Sold Under Agreements To Repurchase Securities Loaned Total FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstDerivativeLiabilitySecuritiesSoldUnderAgreementsToRepurchaseSecuritiesLoanedTotal	41000000	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	17000000	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	1572000000	USD
CY2021Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	2220000000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	2220000000	USD
CY2020Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Derivative Assets FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstDerivativeAssets	35000000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	1098000000	USD
CY2020Q4	jxn	Derivative Collateral Obligation To Return Securities By Counterparty DerivativeCollateralObligationToReturnSecuritiesByCounterparty	890000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	197000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	56000000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	56000000	USD
CY2020Q4	jxn	Financial Instruments Amounts That Have Not Been Off Set Against Derivative Liabilities FinancialInstrumentsAmountsThatHaveNotBeenOffSetAgainstDerivativeLiabilities	35000000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	13000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	8000000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	13000000	USD
CY2020Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	USD
CY2020Q4	us-gaap	Securities Loaned SecuritiesLoaned	13000000	USD
CY2020Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Securities Loaned FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstSecuritiesLoaned	0	USD
CY2020Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	13000000	USD
CY2020Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1100000000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1100000000	USD
CY2020Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Securities Sold Under Agreements To Repurchase FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1100000000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	1169000000	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	1169000000	USD
CY2020Q4	jxn	Financial Instruments Amounts That Have Not Been Offset Against Derivative Liability Securities Sold Under Agreements To Repurchase Securities Loaned Total FinancialInstrumentsAmountsThatHaveNotBeenOffsetAgainstDerivativeLiabilitySecuritiesSoldUnderAgreementsToRepurchaseSecuritiesLoanedTotal	35000000	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	26000000	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	1100000000	USD
CY2020Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	8000000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	279000000	USD
CY2021Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	18000000	USD
CY2021Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3467000000	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1417000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2623000000	USD
CY2021Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	262000000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	248949000000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	310390000000	USD
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	4071000000	USD
CY2021Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	3759000000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	41000000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7871000000	USD
CY2021Q4	us-gaap	Alternative Investment AlternativeInvestment	2813000000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	193000000	USD
CY2020Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	1000000	USD
CY2020Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3454000000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	2220000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2019000000	USD
CY2020Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	340000000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219063000000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	287747000000	USD
CY2020Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	7076000000	USD
CY2020Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	4453000000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	56000000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11585000000	USD
CY2020Q4	us-gaap	Alternative Investment AlternativeInvestment	1991000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	13000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	9000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	261000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	246000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	19000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	11000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	38000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	271000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	401000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-157000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	59000000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	27000000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	21000000	USD
CY2021Q4	jxn	Federal Home Loan Bank Capital Stock Share Price FederalHomeLoanBankCapitalStockSharePrice	100
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	11482000000	USD
CY2021Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	1008000000	USD
CY2021Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	125000000	USD
CY2021Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	36318000000	USD
CY2021Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	894000000	USD
CY2020Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	322000000	USD
CY2021Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5986000000	USD
CY2021Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	1950000000	USD
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	24533000000	USD
CY2021Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2649000000	USD
CY2021Q4	us-gaap	Securities Loaned SecuritiesLoaned	17000000	USD
CY2021Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	0	USD
CY2021Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1572000000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	248949000000	USD
CY2020Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10728000000	USD
CY2020Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	1070000000	USD
CY2020Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	125000000	USD
CY2020Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	38563000000	USD
CY2020Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1276000000	USD
CY2020Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	8384000000	USD
CY2020Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	1478000000	USD
CY2020Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	27519000000	USD
CY2020Q4	us-gaap	Securities Loaned SecuritiesLoaned	13000000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	380000000	USD
CY2020Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1100000000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219063000000	USD
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option Alternative Investments FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOptionAlternativeInvestments	715000000	USD
CY2021	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Acquisition Costs and Deferred Sales Inducements<div style="padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Acquisition Costs</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current accounting guidance, certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred acquisition costs are increased by interest thereon and amortized into income in proportion to anticipated premium revenues for traditional life policies and in proportion to estimated gross profits, including net gains (losses) on derivatives </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and investments, for annuities and interest-sensitive life products. Due to volatility of certain factors that affect gross profits, including net gains (losses) on derivatives and investments, amortization may be a benefit or a charge in any given period. In the event of negative amortization, the related deferred acquisition cost balance is capped at the initial amount capitalized, plus interest. Unamortized deferred acquisition costs are written off when a contract is internally replaced and substantially changed. Deferred acquisition costs are reviewed periodically to ensure that the unamortized portion does not exceed the expected recoverable amounts. The Company’s accounting policy includes reinsurance balances when evaluating recoverability of deferred acquisition costs. Any amount deemed unrecoverable is written off with a charge through deferred acquisition costs amortization. Other than the amounts related to the Athene Reinsurance Transaction in 2020 noted below, no such write-offs were required for 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As available-for-sale debt securities are carried at fair value, an adjustment is made to deferred acquisition costs equal to the change in amortization that would have occurred if such securities had been sold at their stated fair value and the proceeds reinvested at current yields. This adjustment, along with the change in net unrealized gains (losses) on available-for-sale debt securities, net of applicable tax, is credited or charged directly to equity as a component of other comprehensive income. At December 31, 2021 and 2020, deferred acquisition costs decreased by $63 million and $146 million, respectively, to reflect this adjustment.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For variable annuity business, the Company employs a mean reversion methodology that is applied with the objective of adjusting the amortization of deferred acquisition costs that would otherwise be highly volatile due to fluctuations in the level of future gross profits arising from changes in equity market levels. The mean reversion methodology achieves this objective by applying a dynamic adjustment to the assumption for short-term future investment returns. Under this methodology, the projected returns for the next five years are set such that, when combined with the actual returns for the current and preceding two years, the average rate of return over the eight-year period is 7.15% for 2021 and 2020, after external investment management fees. The mean reversion methodology does, however, include a cap and a floor of 15% and 0% per annum, respectively, on the projected return for each of the next five years. At December 31, 2021 and 2020, projected returns under mean reversion were within the range bound by the 15% cap and 0% floor. At both December 31, 2021 and 2020, projected returns after the next five years were set at 7.15%.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the recoverability of previously established deferred acquisition cost assets in accordance with ASC 944-30-35-22. The Company determined it was appropriate to immediately write-off the remaining deferred acquisition costs on the business reinsured to Athene as no future profits will be recognized on this business at this aggregated level of recoverability testing. Accordingly, amortization of deferred acquisition costs for the year ended December 31, 2020 included a write-off of $626 million, related to the blocks of fixed and fixed-index annuity business, as a result of the Athene transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of, and changes, in deferred acquisition costs were as follows (in millions):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"/><td style="width:52.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,897</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,337</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,075</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">789</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">738</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">796</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(519)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">533</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,003</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized investment (gains) losses </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">82</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">289</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(537)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,249</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,897</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,337</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Actuarial Assumption Changes (Unlocking)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:0.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annually, or as circumstances warrant, the Company conducts a comprehensive review of the assumptions used for its estimates of future gross profits underlying the amortization of deferred acquisition costs and deferred sales inducements, as well as the valuation of the embedded derivatives and reserves for life insurance and annuity products with living benefit and death benefit guarantees. These assumptions include, but may not be limited to, policyholder behavior, mortality rates, expenses, projected hedging costs, investment returns and policy crediting rates. Based on this review, the cumulative balances of deferred acquisition costs, deferred sales inducements and life and annuity guaranteed benefit reserves are adjusted with a corresponding benefit or charge to net income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Sales Inducements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain sales inducement costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred sales inducement costs. Bonus interest on deferred fixed annuities and contract enhancements on fixed index annuities and variable annuities are capitalized as deferred sales inducements and included in other assets. Deferred sales inducements (“DSI”) are increased by interest thereon and amortized into income in proportion to estimated gross profits, including net gains (losses) on derivatives and investments. Deferred sales inducements are reviewed periodically to ensure that the unamortized portion does not exceed the expected recoverable amounts. Any amount deemed unrecoverable is written off with a charge through deferred sales inducements amortization. Other than the amounts related to the Athene Reinsurance Transaction in 2020 noted below, no such write-offs were required for 2021, 2020, and 2019.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the recoverability of previously established deferred acquisition costs and deferred sales inducement assets in accordance with ASC 944-30-35-22. The Company determined it was appropriate to immediately write-off the remaining deferred acquisition costs and deferred sales inducement costs on the business reinsured to Athene as no future profits will be recognized on this business at this aggregated level of recoverability testing. Accordingly, amortization of deferred sales inducement costs for the year ended December 31, 2020 included a write-off of $138 million, related to the blocks of fixed and fixed-index annuity business, as a result of the Athene transaction.</span></div><div><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of and changes in deferred sales inducements, which are reported in other assets, were as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"/><td style="width:52.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">145</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of sales inducements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(144)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(22)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized investment losses (gains)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">88</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(80)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, end of year</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">54</span></td></tr></table></div>
CY2021	us-gaap	Deferred Policy Acquisition Costs Period Increase Decrease DeferredPolicyAcquisitionCostsPeriodIncreaseDecrease	-63000000	USD
CY2020	us-gaap	Deferred Policy Acquisition Costs Period Increase Decrease DeferredPolicyAcquisitionCostsPeriodIncreaseDecrease	-146000000	USD
CY2021	jxn	Short Term Investment Expected Return Over Eight Year Period ShortTermInvestmentExpectedReturnOverEightYearPeriod	0.0715
CY2021	jxn	Short Term Investment Expected Return Cap ShortTermInvestmentExpectedReturnCap	0.15
CY2021	jxn	Short Term Investment Expected Return Floor ShortTermInvestmentExpectedReturnFloor	0
CY2021	jxn	Short Term Investment Expected Return Cap ShortTermInvestmentExpectedReturnCap	0.15
CY2021	jxn	Short Term Investment Expected Return Floor ShortTermInvestmentExpectedReturnFloor	0
CY2021	jxn	Short Term Investment Expected Return Over Five Year Period ShortTermInvestmentExpectedReturnOverFiveYearPeriod	0.0715
CY2020	us-gaap	Deferred Policy Acquisition Costs Impairment Loss DeferredPolicyAcquisitionCostsImpairmentLoss	626000000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13897000000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12337000000	USD
CY2018Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	11075000000	USD
CY2021	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	789000000	USD
CY2020	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	738000000	USD
CY2019	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	796000000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	-519000000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	533000000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	1003000000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-82000000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-289000000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	537000000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14249000000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	13897000000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12337000000	USD
CY2020	us-gaap	Deferred Sales Inducement Cost Impairment Loss DeferredSalesInducementCostImpairmentLoss	138000000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1000000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	54000000	USD
CY2018Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	145000000	USD
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1000000	USD
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	3000000	USD
CY2019	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	11000000	USD
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	2000000	USD
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	144000000	USD
CY2019	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	22000000	USD
CY2021	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	1000000	USD
CY2020	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	88000000	USD
CY2019	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-80000000	USD
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1000000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1000000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	54000000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	12000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	13000000	USD
CY2021	jxn	Investment Management Fees InvestmentManagementFees	104000000	USD
CY2020	jxn	Investment Management Fees InvestmentManagementFees	60000000	USD
CY2019	jxn	Investment Management Fees InvestmentManagementFees	0	USD
CY2020	jxn	Reinsurance Agreement Ceding Commission ReinsuranceAgreementCedingCommission	1202000000	USD
CY2020	us-gaap	Reinsurance Loss On Uncollectible Accounts In Period Amount ReinsuranceLossOnUncollectibleAccountsInPeriodAmount	2520000000	USD
CY2020	jxn	Write Off Of Deferred Acquisition Costs And Deferred Sales Inducements WriteOffOfDeferredAcquisitionCostsAndDeferredSalesInducements	764000000	USD
CY2020	jxn	Pre Tax Gain Loss On Coinsurance Agreement Transaction PreTaxGainLossOnCoinsuranceAgreementTransaction	2082000000	USD
CY2020	jxn	Reinsurance Assets Written Off ReinsuranceAssetsWrittenOff	30100000000	USD
CY2020	jxn	Reinsurance Ceded Reserves ReinsuranceCededReserves	27600000000	USD
CY2021Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	28892000000	USD
CY2020Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	31860000000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	29007000000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	31972000000	USD
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	392000000	USD
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	309000000	USD
CY2019	us-gaap	Direct Premiums Earned DirectPremiumsEarned	558000000	USD
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	USD
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	47000000	USD
CY2019	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	456000000	USD
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	USD
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	196000000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	913000000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1284000000	USD
CY2019	us-gaap	Ceded Premiums Earned CededPremiumsEarned	447000000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	133000000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	160000000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	567000000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1415000000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1524000000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1441000000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	876000000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	749000000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	794000000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	863000000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	666000000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	665000000	USD
CY2021	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	515000000	USD
CY2020	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	323000000	USD
CY2019	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	106000000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1464000000	USD
CY2021Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	863000000	USD
CY2020Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	861000000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	33126000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	35270000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	4187000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits Life LiabilityForFuturePolicyBenefitsLife	4535000000	USD
CY2021Q4	us-gaap	Guaranteed Interest Contracts GuaranteedInterestContracts	5477000000	USD
CY2020Q4	us-gaap	Guaranteed Interest Contracts GuaranteedInterestContracts	8509000000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1050000000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1110000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits Disability And Accident Benefits LiabilityForFuturePolicyBenefitsDisabilityAndAccidentBenefits	1204000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits Disability And Accident Benefits LiabilityForFuturePolicyBenefitsDisabilityAndAccidentBenefits	1257000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits Individual And Group Annuities And Supplementary Contracts LiabilityForFuturePolicyBenefitsIndividualAndGroupAnnuitiesAndSupplementaryContracts	4895000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits Individual And Group Annuities And Supplementary Contracts LiabilityForFuturePolicyBenefitsIndividualAndGroupAnnuitiesAndSupplementaryContracts	5220000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits Other Contracts LiabilityForFuturePolicyBenefitsOtherContracts	816000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits Other Contracts LiabilityForFuturePolicyBenefitsOtherContracts	859000000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	17629000000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	21490000000	USD
CY2021Q4	jxn	Annuity Account Values AnnuityAccountValues	12188000000	USD
CY2021Q4	us-gaap	Ceded Premiums Payable CededPremiumsPayable	24956000000	USD
CY2021Q4	jxn	Annuity Account Values And Ceded Premiums Payable AnnuityAccountValuesAndCededPremiumsPayable	37144000000	USD
CY2020Q4	jxn	Annuity Account Values AnnuityAccountValues	12744000000	USD
CY2020Q4	us-gaap	Ceded Premiums Payable CededPremiumsPayable	26776000000	USD
CY2020Q4	jxn	Annuity Account Values And Ceded Premiums Payable AnnuityAccountValuesAndCededPremiumsPayable	39520000000	USD
CY2021Q4	jxn	Account Value Interest Sensitive Life Insurance AccountValueInterestSensitiveLifeInsurance	7348000000	USD
CY2020Q4	jxn	Account Value Interest Sensitive Life Insurance AccountValueInterestSensitiveLifeInsurance	7622000000	USD
CY2021Q4	jxn	Retro Treaties Account Value RetroTreatiesAccountValue	4222000000	USD
CY2020Q4	jxn	Retro Treaties Account Value RetroTreatiesAccountValue	4214000000	USD
CY2021Q4	jxn	Interest Sensitive Life Insurance And Retro Treaties Account Values InterestSensitiveLifeInsuranceAndRetroTreatiesAccountValues	11570000000	USD
CY2020Q4	jxn	Interest Sensitive Life Insurance And Retro Treaties Account Values InterestSensitiveLifeInsuranceAndRetroTreatiesAccountValues	11836000000	USD
CY2021Q4	jxn	Funding Agreement FundingAgreement	2000000000.0	USD
CY2020Q4	jxn	Funding Agreement FundingAgreement	1900000000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	248900000000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	248900000000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219100000000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219100000000	USD
CY2021	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Based On Simple Interest Rate Of Five Percent NetAmountAtRiskByProductAndGuaranteeCompoundInterestRateBasedOnSimpleInterestRateOfFivePercent	0.041
CY2021	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Based On Simple Interest Rate Of Eight Percent NetAmountAtRiskByProductAndGuaranteeCompoundInterestRateBasedOnSimpleInterestRateOfEightPercent	0.060
CY2021	jxn	Net Amount At Risk By Product And Guarantee Compound Interest Rate Period NetAmountAtRiskByProductAndGuaranteeCompoundInterestRatePeriod	P10Y
CY2021Q4	us-gaap	Schedule Of Fair Value Of Separate Accounts By Major Category Of Investment Fair Value ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue	219324000000	USD
CY2020Q4	us-gaap	Schedule Of Fair Value Of Separate Accounts By Major Category Of Investment Fair Value ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue	193904000000	USD
CY2020Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1418000000	USD
CY2019Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1283000000	USD
CY2021	us-gaap	Liabilities For Guarantees On Long Duration Contracts Incurred Benefits1 LiabilitiesForGuaranteesOnLongDurationContractsIncurredBenefits1	55000000	USD
CY2020	us-gaap	Liabilities For Guarantees On Long Duration Contracts Incurred Benefits1 LiabilitiesForGuaranteesOnLongDurationContractsIncurredBenefits1	270000000	USD
CY2021	us-gaap	Liabilities For Guarantees On Long Duration Contracts Payment For Benefits LiabilitiesForGuaranteesOnLongDurationContractsPaymentForBenefits	103000000	USD
CY2020	us-gaap	Liabilities For Guarantees On Long Duration Contracts Payment For Benefits LiabilitiesForGuaranteesOnLongDurationContractsPaymentForBenefits	135000000	USD
CY2021Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1370000000	USD
CY2020Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Gross LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityGross	1418000000	USD
CY2021Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitReserveLiability	2626000000	USD
CY2020Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitReserveLiability	5592000000	USD
CY2021Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit With Guaranteed Payments Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitWithGuaranteedPaymentsReserveLiability	196000000	USD
CY2020Q4	jxn	Long Duration Contract Guaranteed Minimum Withdrawal Benefit With Guaranteed Payments Reserve Liability LongDurationContractGuaranteedMinimumWithdrawalBenefitWithGuaranteedPaymentsReserveLiability	181000000	USD
CY2021Q4	jxn	Long Duration Contracts Lifetime Income Rider Liability LongDurationContractsLifetimeIncomeRiderLiability	37000000	USD
CY2021Q4	jxn	Long Duration Contracts Lifetime Income Rider Liability LongDurationContractsLifetimeIncomeRiderLiability	37000000	USD
CY2020Q4	jxn	Long Duration Contracts Lifetime Income Rider Liability LongDurationContractsLifetimeIncomeRiderLiability	18000000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2649000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	322000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1345000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q4	jxn	Long Term Debt Maturity Year Five And Thereafter LongTermDebtMaturityYearFiveAndThereafter	1299000000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2649000000	USD
CY2021Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2400000000	USD
CY2021Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	95000000	USD
CY2020Q4	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	96000000	USD
CY2019Q4	us-gaap	Payments Of Dividends PaymentsOfDividends	350000000	USD
CY2021Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	380000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-71000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-80000000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	305000000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-73000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-78000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	305000000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	653000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-703000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-674000000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22000000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-73000000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	675000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-776000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-674000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-369000000	USD
CY2021	jxn	Income Tax Expense Benefit Net Interest Related To Tax Refunds IncomeTaxExpenseBenefitNetInterestRelatedToTaxRefunds	-24000000	USD
CY2021	jxn	Income Tax Expense Benefit Uncertain Tax Positions IncomeTaxExpenseBenefitUncertainTaxPositions	-3000000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	795000000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-522000000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-182000000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	15000000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-56000000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2021	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	146000000	USD
CY2020	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	158000000	USD
CY2019	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	171000000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1000000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1000000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-16000000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	46000000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	61000000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	40000000	USD
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-53000000	USD
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-16000000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	11000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	23000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-854000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-369000000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.159
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.426
CY2020	jxn	Effective Income Tax Rate Reconciliation State And Local Income Taxes True Up Of Prior Periods Amount EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesTrueUpOfPriorPeriodsAmount	-33000000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	395000000	USD
CY2021	jxn	Income Tax Paid Refunded Excluding Interest IncomeTaxPaidRefundedExcludingInterest	-314000000	USD
CY2021	jxn	Income Tax Paid Refunded Interest IncomeTaxPaidRefundedInterest	-24000000	USD
CY2021	jxn	Income Tax Paid Refunded Refunds From Overpayment IncomeTaxPaidRefundedRefundsFromOverpayment	-73000000	USD
CY2021Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	2695000000	USD
CY2020Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	3259000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	181000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	165000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1128000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	1121000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	329000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	306000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	55000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4325000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4958000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4323000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4956000000	USD
CY2021Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2873000000	USD
CY2020Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2812000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	23000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	0	USD
CY2021Q4	jxn	Deferred Tax Liabilities Unrealized Gains On Investments DeferredTaxLiabilitiesUnrealizedGainsOnInvestments	453000000	USD
CY2020Q4	jxn	Deferred Tax Liabilities Unrealized Gains On Investments DeferredTaxLiabilitiesUnrealizedGainsOnInvestments	1024000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	20000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	62000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3369000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3898000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	954000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1058000000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2000000	USD
CY2021Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	USD
CY2020Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	USD
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	6000000	USD
CY2020Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	6000000	USD
CY2021Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	1584000000	USD
CY2020Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	143000000	USD
CY2021Q4	jxn	Operating Loss Carryforwards Section382 Annual Limitation OperatingLossCarryforwardsSection382AnnualLimitation	21000000	USD
CY2021Q4	jxn	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	52000000	USD
CY2021Q4	jxn	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	109000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	33000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	jxn	Unrecognized Tax Benefits Increase Decrease Resulting From Tax Reserves Position UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromTaxReservesPosition	-2000000	USD
CY2020	jxn	Unrecognized Tax Benefits Increase Decrease Resulting From Tax Reserves Position UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromTaxReservesPosition	0	USD
CY2021	jxn	Unrecognized Tax Benefits Decrease Resulting From Drd Short Term Gain Position UnrecognizedTaxBenefitsDecreaseResultingFromDRDShortTermGainPosition	0	USD
CY2020	jxn	Unrecognized Tax Benefits Decrease Resulting From Drd Short Term Gain Position UnrecognizedTaxBenefitsDecreaseResultingFromDRDShortTermGainPosition	31000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	5000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	43000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	51000000	USD
CY2021	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	33000000	USD
CY2020	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	28000000	USD
CY2019	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	36000000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	12000000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	14000000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	5000000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	4000000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	5000000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	3000000	USD
CY2021	us-gaap	Lease Cost LeaseCost	8000000	USD
CY2020	us-gaap	Lease Cost LeaseCost	12000000	USD
CY2019	us-gaap	Lease Cost LeaseCost	15000000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	12000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6000000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	15000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.037
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	11000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	49000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	43000000	USD
CY2021Q4	jxn	Equity Compensation Reserve EquityCompensationReserve	0	USD
CY2020Q4	jxn	Equity Compensation Reserve EquityCompensationReserve	8000000	USD
CY2021Q4	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	0	USD
CY2020Q4	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	4000000	USD
CY2021	jxn	Share Based Compensation Arrangement By Share Based Payment Award Plan Term ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanTerm	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	11000000	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	129000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	79000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	26000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17000000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	143000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M8D
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6100000000	USD
CY2020Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	4800000000	USD
CY2021	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	136000000	USD
CY2020	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-1933000000	USD
CY2019	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-1058000000	USD
CY2021Q4	jxn	Statutory Basis Value Of Business Acquired StatutoryBasisValueOfBusinessAcquired	33000000	USD
CY2020Q4	jxn	Statutory Basis Value Of Business Acquired StatutoryBasisValueOfBusinessAcquired	82000000	USD
CY2021	jxn	Defined Contribution Plan Eligibility Number Of Service Hours In Twelve Month Period DefinedContributionPlanEligibilityNumberOfServiceHoursInTwelveMonthPeriod	1000	H
CY2021	jxn	Defined Contribution Plan Requisite Service Period DefinedContributionPlanRequisiteServicePeriod	P12M
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	32000000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	34000000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	32000000	USD
CY2021Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	564000000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	595000000	USD
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	54000000	USD
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	56000000	USD
CY2019	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	70000000	USD
CY2021	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1126000000	USD
CY2020	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	907000000	USD
CY2019	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	861000000	USD
CY2021	jxn	Other Commission Expense OtherCommissionExpense	1042000000	USD
CY2020	jxn	Other Commission Expense OtherCommissionExpense	1020000000	USD
CY2019	jxn	Other Commission Expense OtherCommissionExpense	1074000000	USD
CY2021	jxn	Ceding Commission And Expense Reimbursement Write Off CedingCommissionAndExpenseReimbursementWriteOff	0	USD
CY2020	jxn	Ceding Commission And Expense Reimbursement Write Off CedingCommissionAndExpenseReimbursementWriteOff	0	USD
CY2019	jxn	Ceding Commission And Expense Reimbursement Write Off CedingCommissionAndExpenseReimbursementWriteOff	66000000	USD
CY2021	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	0	USD
CY2020	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	1202000000	USD
CY2019	jxn	Ceded Commission Gain Loss CededCommissionGainLoss	0	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1083000000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	996000000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	994000000	USD
CY2021	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-789000000	USD
CY2020	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-737000000	USD
CY2019	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-797000000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2462000000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	984000000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	2066000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-1829000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	2598000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	3898000000	USD
CY2021	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	90000000	USD
CY2020	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	131000000	USD
CY2019	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	-661000000	USD
CY2021	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	375000000	USD
CY2020	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	-602000000	USD
CY2019	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	-680000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1364000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2127000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2557000000	USD
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	713000000	USD
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	704000000	USD
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-65000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2077000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1423000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2622000000	USD
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37785738	shares
CY2020	jxn	Stock Issued During Period Shares Issued For Debt Restructure StockIssuedDuringPeriodSharesIssuedForDebtRestructure	46182568	shares
CY2021Q4	jxn	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	104960.3836276
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5778649	shares
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	211000000	USD
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	36.51
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10496037	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94464343	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5778649	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88685694	shares
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	875000000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	525000000	USD
CY2019	jxn	Dividends Common Stock Exchange For Note Payable DividendsCommonStockExchangeForNotePayable	350000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7200000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3183000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1634000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-497000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93994520	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67658901	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37785738	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	470991	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94465511	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67658901	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37785738	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	33.86
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.16
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	33.69
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.16
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Cost SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost	71343000000	USD
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	74227000000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	14249000000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	17629000000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	59689000000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	13897000000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	21490000000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	64538000000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	12337000000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	19200000000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	64305000000	USD
CY2021	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	133000000	USD
CY2021	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	3429000000	USD
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	868000000	USD
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	521000000	USD
CY2021	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2462000000	USD
CY2020	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	160000000	USD
CY2020	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2829000000	USD
CY2020	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	1210000000	USD
CY2020	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	-389000000	USD
CY2020	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	984000000	USD
CY2019	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	567000000	USD
CY2019	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	3143000000	USD
CY2019	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	1641000000	USD
CY2019	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	-981000000	USD
CY2019	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2066000000	USD
CY2021Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	105704000000	USD
CY2021Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	63548000000	USD
CY2021Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	16358000000	USD
CY2021Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	58514000000	USD
CY2021Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.280
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	392000000	USD
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	USD
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	133000000	USD
CY2021	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.316
CY2020Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	118328000000	USD
CY2020Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	72188000000	USD
CY2020Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	17034000000	USD
CY2020Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	63174000000	USD
CY2020Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.270
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	309000000	USD
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	196000000	USD
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	47000000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	160000000	USD
CY2020	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.295
CY2019Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	142233000000	USD
CY2019Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	88435000000	USD
CY2019Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	18206000000	USD
CY2019Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	72004000000	USD
CY2019Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.253
CY2019	us-gaap	Direct Premiums Earned DirectPremiumsEarned	558000000	USD
CY2019	us-gaap	Ceded Premiums Earned CededPremiumsEarned	447000000	USD
CY2019	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	456000000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	567000000	USD
CY2019	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.804
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	208000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	11000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	102000000	USD
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	117000000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	10000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	198000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	208000000	USD

Files In Submission

Name	View Source	Status
0001822993-22-000009-index-headers.html	Edgar Link	pending
0001822993-22-000009-index.html	Edgar Link	pending
0001822993-22-000009.txt	Edgar Link	pending
0001822993-22-000009-xbrl.zip	Edgar Link	pending
R11.htm	Edgar Link	pending
exhibit1025formofnoticeand.htm	Edgar Link	pending
exhibit1026formofnoticeand.htm	Edgar Link	pending
exhibit1027formofnoticeand.htm	Edgar Link	pending
exhibit1028formofnoticeand.htm	Edgar Link	pending
exhibit1029formofnoticeand.htm	Edgar Link	pending
exhibit1030formofnoticeand.htm	Edgar Link	pending
exhibit1031formofnoticeand.htm	Edgar Link	pending
exhibit1032formofnoticeand.htm	Edgar Link	pending
exhibit1033formofnoticeand.htm	Edgar Link	pending
exhibit1034formofnoticeand.htm	Edgar Link	pending
exhibit1035formofequityawa.htm	Edgar Link	pending
exhibit1036formofequityawa.htm	Edgar Link	pending
exhibit1037equityawardexch.htm	Edgar Link	pending
exhibit1038formofequityawa.htm	Edgar Link	pending
exhibit1039equityawardexch.htm	Edgar Link	pending
exhibit10402021directorfou.htm	Edgar Link	pending
exhibit211listofsubsidiari.htm	Edgar Link	pending
exhibit231auditorsconsent_.htm	Edgar Link	pending
exhibit311fy_202110-k.htm	Edgar Link	pending
exhibit312fy_202110-k.htm	Edgar Link	pending
exhibit321fy_202110-k.htm	Edgar Link	pending
exhibit322fy_202110-k.htm	Edgar Link	pending
exhibit46descriptionofsecu.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_0b.jpg	Edgar Link	pending
jxn-20211231.htm	Edgar Link	pending
jxn-20211231.xsd	Edgar Link	pending
jxn-20211231_cal.xml	Edgar Link	unprocessable
jxn-20211231_def.xml	Edgar Link	unprocessable
jxn-20211231_g1.jpg	Edgar Link	pending
jxn-20211231_g2.jpg	Edgar Link	pending
jxn-20211231_htm.xml	Edgar Link	completed
jxn-20211231_lab.xml	Edgar Link	unprocessable
jxn-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JXN
Jackson Financial Inc. Stock $jxn

2021 Q4 Form 10-K Financial Statement

#000182299322000009 Filed on March 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN Jackson Financial Inc. Stock $jxn

2021 Q4 Form 10-K Financial Statement

#000182299322000009 Filed on March 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN
Jackson Financial Inc. Stock $jxn